Fluoxetine hydrochloride (Prozac)-induced pulmonary disease.
We describe a patient who developed progressive dyspnea, lung infiltrates, and restrictive lung disease in association with the antidepressant fluoxetine hydrochloride (Prozac). The pathologic findings were consistent with hypersensitivity pneumonitis. An associated pulmonary phospholipidosis was also noted.
Gonzalez-Rothi
R J
RJ
Department of Medicine, University of Florida College of Medicine, Gainesville, USA.
Zander
D S
DS
Ros
P R
PR
D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D004342:Drug Hypersensitivity; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D010743:Phospholipids / Q000378:metabolism; D011859:Radiography
D010743:Phospholipids; D005473:Fluoxetine